Financials

  • Market Capitalization 758.13 M
  • Employee 29
  • Founded 2018
  • CEO N/A
  • Website www.climbbio.com
  • Headquarter Delaware, United States
  • FIGI BBG00ZNKL0K6
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-8.9
Relación precio/flujo de caja
-1 589.13

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
2638
RIGL
Rigel Pharmaceuticals, Inc. - Common Stock
41.17 USD-0.31%-0.17%+22.75%+36.64%761.73 M USD
2640
OMER
Omeros Corporation - Common Stock
10.50 USD+4.90%+2.14%+12.42%+189.26%759.94 M USD
2646
SPRY
ARS Pharmaceuticals, Inc. - Common Stock
7.61 USD-1.68%+0.13%-22.35%-17.37%755.70 M USD
2677
AURA
Aura Biosciences, Inc. - Common Stock
7.00 USD0.00%-0.43%+9.03%+6.71%723.71 M USD